Literature DB >> 7433322

Beta-adrenoceptor-blocking drugs, growth hormone and acromegaly.

J Feely.   

Abstract

Chronic treatment with oxprenolol or propranolol in active hypertensive patients was associated with elevation of serum growth hormone (GH). Propranolol, 80 mg orally, caused a marked rise in GH in 3 of 4 acromegalic patients.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7433322      PMCID： PMC2425903          DOI： 10.1136/pgmj.56.654.236

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  10 in total

1.  Adrenergic modulation of growth hormone secretion in acromegaly: alpha- and beta-adrenergic blockade produce qualitatively normal responses but no effect on L-dopa suppresion.

Authors:  P E Cryer; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1977-05       Impact factor: 5.958

Review 2.  Medical treatment of acromegaly.

Authors:  I D Goldfine
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

3.  Relationship of the adrenergic nervous system and growth hormone release in normal adults and children with various growth disorders.

Authors:  P A Lee; R G Thompson; R M Blizzard
Journal:  Metabolism       Date:  1974-07       Impact factor: 8.694

4.  Regulation of growth hormone secretion in acromegaly.

Authors:  P E Cryer; W H Daughaday
Journal:  J Clin Endocrinol Metab       Date:  1969-03       Impact factor: 5.958

5.  Propranolol-augmented, exercise-induced human growth hormone release.

Authors:  N K Maclaren; G E Taylor; S Raiti
Journal:  Pediatrics       Date:  1975-11       Impact factor: 7.124

6.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13

7.  Comparison of TRF, propranolol-glucagon, insulin and glucose stimulation tests in acromegaly.

Authors:  G Coutant; M Vandeweghe; A Vermeulen
Journal:  Horm Metab Res       Date:  1977-01       Impact factor: 2.936

8.  Cardiac size and function in acromegaly.

Authors:  J B Martins; R E Kerber; B M Sherman; M L Marcus; J C Ehrhardt
Journal:  Circulation       Date:  1977-11       Impact factor: 29.690

9.  Pathogenesis of prolactin-secreting pituitary adenomas.

Authors:  B M Sherman; C E Harris; J Schlechte; T M Duello; N S Halmi; J VanGilder; F K Chapler; D K Granner
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

10.  Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.

Authors:  H Imura; Y Kato; M Ikeda; M Morimoto; M Yawata
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.